Mechanisms of Resistance and Treatment of Relapse After CAR T-Cell Therapy for Large B-Cell Lymphoma and Multiple Myeloma

Focusing on both large B-cell lymphoma and multiple myeloma, investigators review resistance mechanisms, explore therapeutic avenues to overcome resistance to CAR T-cell therapies, and discuss the management of patients who have relapsed after CAR T-cell therapy.